MYC and neoplasm: Down‐regulation of SRC‐1 decreased HCC cell proliferation and impaired tumour maintenance in HCC xenografts, and knockdown of SRC‐1 reduced protein levels of the proliferation marker proliferating cell nuclear antigen (PCNA) and the oncogene c‐Myc.